Serum prostate specific antigen as a predictor of survival in prostate cancer patients treated with second-line hormonal therapy (CALGB 9181)

Category Primary study
JournalProstate Journal
Year 2001
This article has no abstract
Epistemonikos ID: 0b6eab1d98f9c737a5efe1e2e02d1c38379206ee
First added on: Feb 03, 2025